SCHEMBL7679832

SCHEMBL7679832

[CH2]c1ccc(OCCC)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.43
LTA4H P09960 1/20 0.42
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 3/20 0.40
HTR1A P08908 1/20 0.40
HTR1B P28222 1/20 0.40
PDK2 Q15119 1/20 0.39
MEN1 O00255 2/20 0.39
KAT6A Q92794 2/20 0.39
C3AR1 Q16581 1/20 0.38
MAOA P21397 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7682786 0.85 NQO1 (0.50) LTA4HCA12CA1CA7CA9
SCHEMBL2212307 0.82 LTA4H (0.46) MAOBLTA4HCA12CA1CA2
SCHEMBL17432926 0.81 MRGPRX4 (0.47) MAOBLTA4HCA12CA1CA2
SCHEMBL5248264 0.79 LTA4H (0.43) MAOBLTA4HCA12CA1CA2
SCHEMBL4738402 0.79 LTA4H (0.37) MAOBLTA4HCA12CA1CA2
SCHEMBL28767196 0.78 MAPT (0.51) MAOBLTA4HCA12CA1CA2
SCHEMBL17433278 0.78 GPR84 (0.50) MAOBLTA4HCA12CA1CA2
SCHEMBL9931761 0.78 NSD2 (0.45) MAOBLTA4HCA12CA1CA2
SCHEMBL19059333 0.78 CA12 (0.45) MAOBLTA4HCA12CA1CA2
SCHEMBL25797422 0.78 LTA4H (0.50) MAOBLTA4HCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US claimed